Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Formulation development of valsartan tablets: employing

  • At: 2014 FIP Congress in Bangkok (Thailand)
  • Type: Poster
  • By: TANNIRU, Adi Narayana (Vikas Institute of pharmaceutical sciences, Industrial pharmacy, Rajahmundry, India)
  • Co-author(s): Chowdary, K.P.R. (Vikas Institute of pharmaceutical sciences, Rajahmundry, India)
    Narayana, Tanniru Venkata (Vikas Institute of pharmaceutical sciences, Rajahmundry, India)
    Kunderu, Ravishankar (Vikas Institute of pharmaceutical sciences, Rajahmundry, India)
    S, Muralidhar (Vikas Institute of pharmaceutical sciences, Rajahmundry, India)
    Sumalatha, G. (Vikas Institute of pharmaceutical sciences, Rajahmundry, India)
    Vasanth Kumar, P. (Vikas Institute of pharmaceutical sciences, Rajahmundry, India)
    Anusha, J.S.K. (Dr.H.L.T college of pharmacy, Bangalore, India)
    Naga Laksmi, Naga Lakshmi (Dr.H.L.T college of pharmacy, Bangalore, India)
    Nageswara Rao, R. (Dr.H.L.T college of pharmacy, Bangalore, India)
  • Abstract:

    Introduction: Valsartan, a BCS class II antihypertensive drug is poorly soluble in aqueous fluids and needs enhancement in the dissolution rate in its formulation development to improve its oral bioavailability and therapeutic efficacy. Among the various approaches cyclodextrin complexation and use of surfactants gained good acceptance in industry ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses